1.23 USD
▲+0.02+9.82%
盘后 1.11 -0.89%
2026-08-03
市值
$5.74M
市盈率
—
EPS
-1.89
股息率
—
52 周区间
0.85 – 6.92
成交量
72.72K
Beta
1.27
目标价
—
52W 低 0.8552W 高 6.92
价格走势
公司简介
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally. It offers Lumacyn, a skin toner; Regenacyn, a prescription scar gel; Reliefacyn to alleviate red bumps, rashes, shallow skin fisures, sunburn, peeling, and eczema/atopic dermatitis; Gramaderm for the treatment of topical mild to moderate acne; Epicyn, an antimicrobial facial c...